Literature DB >> 18098338

A mouse model of a human multiple GIST family with KIT-Asp820Tyr mutation generated by a knock-in strategy.

N Nakai1, T Ishikawa, A Nishitani, N-N Liu, M Shincho, H Hao, K Isozaki, T Kanda, T Nishida, J Fujimoto, S Hirota.   

Abstract

Several families exhibiting multiple gastrointestinal stromal tumours (GISTs) and germline c-kit gene mutations at exons 8, 11, 13, or 17 have been reported. These patients also exhibit diffuse hyperplasia of the interstitial cells of Cajal (ICCs) as a pre-existing lesion of multiple GISTs. We generated a mouse model of a family with germline c-kit gene mutation at exon 17, and compared the phenotypes between the mice and humans. The mouse counterpart (KIT-Asp818Tyr) of the human KIT-Asp820Tyr mutation was transmitted into germline by a knock-in strategy. Mating of male and female heterozygotes (KIT-Asp818Tyr/+) resulted in the generation of homozygotes (KIT-Asp818Tyr/KIT-Asp818Tyr). Histological examination revealed that all heterozygotes had both a small KIT-positive mesenchymal tumour at the caecum, consistent with GIST, and KIT-positive diffuse spindle-shaped cell proliferation in the distal oesophagus, stomach, proximal duodenum, and colon consistent with ICC hyperplasia. All homozygotes exhibited a larger caecal tumour and more prominent spindle-shaped cell proliferation compared with the heterozygous mice, and they usually died within 10 weeks after birth, likely due to ileus. The small intestine of both genotypes showed no apparent morphological abnormality, and autonomous contraction of the ileal segments appeared normal. Western blotting demonstrated that the caecal tumours expressed phosphorylated KIT, MAPK, Stat1, and Stat5. These mutant mice are considered to be useful for further investigation of the mechanism of GIST development as a result of ICC hyperplasia and for assessment of the in vivo effects of drugs against molecular targets. Copyright (c) 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18098338     DOI: 10.1002/path.2296

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  22 in total

Review 1.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

2.  Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT.

Authors:  Sabrina Brahimi-Adouane; Jean-Baptiste Bachet; Séverine Tabone-Eglinger; Frédéric Subra; Claude Capron; Jean-Yves Blay; Jean-François Emile
Journal:  Mol Oncol       Date:  2012-10-30       Impact factor: 6.603

3.  ETV1-Positive Cells Give Rise to BRAFV600E -Mutant Gastrointestinal Stromal Tumors.

Authors:  Leili Ran; Devan Murphy; Jessica Sher; Zhen Cao; Shangqian Wang; Edward Walczak; Youxin Guan; Yuanyuan Xie; Shipra Shukla; Yu Zhan; Cristina R Antonescu; Yu Chen; Ping Chi
Journal:  Cancer Res       Date:  2017-05-24       Impact factor: 12.701

4.  Characterization of various types of mast cells derived from model mice of familial gastrointestinal stromal tumors with KIT-Asp818Tyr mutation.

Authors:  Noriko Kajimoto; Norihiro Nakai; Mizuka Ohkouchi; Yuka Hashikura; Ning-Ning Liu-Kimura; Koji Isozaki; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 5.  Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and Mouse.

Authors:  Thomas Nolte; Patricia Brander-Weber; Charles Dangler; Ulrich Deschl; Michael R Elwell; Peter Greaves; Richard Hailey; Michael W Leach; Arun R Pandiri; Arlin Rogers; Cynthia C Shackelford; Andrew Spencer; Takuji Tanaka; Jerrold M Ward
Journal:  J Toxicol Pathol       Date:  2016-02-13       Impact factor: 1.628

6.  Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice.

Authors:  Patrick P Lin; Manoj K Pandey; Fenghua Jin; A Kevin Raymond; Haruhiko Akiyama; Guillermina Lozano
Journal:  Carcinogenesis       Date:  2009-07-27       Impact factor: 4.944

7.  Changes in the structure and function of ICC networks in ICC hyperplasia and gastrointestinal stromal tumors.

Authors:  Joong Goo Kwon; Sung Jin Hwang; Grant W Hennig; Yulia Bayguinov; Conor McCann; Hui Chen; Ferdinand Rossi; Peter Besmer; Kenton M Sanders; Sean M Ward
Journal:  Gastroenterology       Date:  2008-11-01       Impact factor: 22.682

Review 8.  Gastrointestinal stromal tumor: a bridge between bench and bedside.

Authors:  Toshirou Nishida; Tsuyoshi Takahashi; Yasuaki Miyazaki
Journal:  Gastric Cancer       Date:  2010-01-05       Impact factor: 7.370

Review 9.  Gastrointestinal stromal tumors: past, present, and future.

Authors:  Yukihiko Kitamura
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

10.  Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model.

Authors:  M A Pantaleo; L Landuzzi; G Nicoletti; C Nanni; S Boschi; G Piazzi; D Santini; M Di Battista; P Castellucci; F Lodi; S Fanti; P-L Lollini; G Biasco
Journal:  Clin Exp Med       Date:  2009-02-19       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.